Chlamydial infection and progression of carotid atherosclerosis in patients on regular haemodialysis

Nephrology Dialysis Transplantation

Volumn 19, Issue 10, 2004, Pages 2539-2546

  Kato, Akihiko ^a   Takita, Takako ^b   Maruyam, Yukitaka ^b   Hishida, Akira ^c  

^a SHIZUOKA CANCER CENTER   (Japan)

^b Maruyama Hospital   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carotid wall intima medial thickness; Chlamydia pneumoniae; Haemodialysis; Hypoalbuminaemia; Interleukin 6

Indexed keywords

ALBUMIN; BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CREATININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 6;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SERODIAGNOSIS;

AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CREATININE; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-6; INTRACRANIAL ARTERIOSCLEROSIS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TUNICA INTIMA; TUNICA MEDIA;

EID: 5444252167     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh416     Document Type: Article

References (27)

1. Oh J, Wunsch R, Turzer Bahner M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105
2. Amann K, Tornig J, Kugel B et al. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 2003; 63: 1296-1301
3. Kato A, Takita T, Maruyama Y et al. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003; 64: 1472-1479
4. Zoccali C, Benedetto FA, Mallamaci F et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. J Hypertens 2000; 18: 1207-1213
5. Stenvinkel P, Heimbürger O, Jogenstrand T et al. Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? Kidney Int 1999; 55: 2531-2532
6. Kato A, Odamaki M, Takita T et al. Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 2002; 61: 1143-1152
7. Stenvinkel P, Heimbürger O, Jogenstrand T. Elevated interlukin-6 predicts progressive carotid atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 2002; 39: 274-282
8. Song H, Tasaki H, Yashiro A et al. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure. Clin Nephrol 2001; 56: 346-352
9. Muller J, Nyvad O, Larsen NA et al. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in dialysis patients, renal transplant recipients and healthy controls. Scand J Clin Lab Invest 2002; 62: 503-509
10. Haubitz M, Brunkhorst R. C-reactive protein and chronic Chlamydia pneumoniae infection-long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 809-815
11. Wolf SC, Mayer O, Jurgens S et al. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 2003; 59: 273-279
12. Bellomo G, Lippi G, Saronio P et al. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: A prospective study. J Nephrol 2003; 16: 245-251
13. Zoccali C, Mallamaci F, Tripepi G et al. Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD). Kidney Int 2003; 64: 579-584
14. Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
15. Hu H, Pierce GN, Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999; 103: 747-753
16. Kalayoglu MV, Libby P, Byrne G. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002; 288: 2724-2731
17. Bloemenkamp DGM, Mali WPT, Visseren FLJ, van der Graaf Y. Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: Does study design influence results? Am Heart J 2003; 145; 409-417
18. Maeda N, Sawayama Y, Tatsukawa M et al. Carotid artery lesions and atherosclerosis risk factors in Japanese hemodialysis patients. Atherosclerosis 2003; 169: 183-192
19. Zhu J, Nieto FJ, Horne BD et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103: 45-51
20. Espinola-Klein C, Rupprecht HJ, Blankenberg S et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002; 33: 2581-2586
21. Ishizaka N, Ishizaka Y, Takahashi E et al. Association between hepatitis C virus seropositivity, carotid artery plaque, and intima-media thickening. Lancet 2002; 359: 133-135
22. Ishizaka Y, Ishizaka N, Takahashi E et al. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 2003; 67: 6-30
23. Salonen RM, Nyyssönen K, Kaikkonen J et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression. The antioxidant supplementation in atherosclerosis prevention (ASAP) study. Circulation 2003; 107: 947-953
24. Dowell SF, Peeling RW, Boman J et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-503
25. Tsirpanlis G, Chatzipanagiotou S, Ioannidis A et al. Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells: correlation with inflammatory and atherosclerosis in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 918-923
26. Tsirpanlis G, Bagos P, Ioannou D et al. The viability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 150-157
27. Pecoits-Filho R, Stenvinkel P, Marchelewska A et al. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int 2003; 63 [Suppl 84] : S172-S176